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Abstract
 
Wild-type (WT) and targeted-mutant mice incapable of making 
 
ab 
 
T cells, 
 
gd 
 
T cells, class I
major histocompatibility complex (MHC), class II MHC, interferon (IFN)-
 
g
 
, or inducible ni-
 
tric oxide synthase (NOS2), were infected with 
 
Mycobacterium tuberculosis
 
 (Mtb) by aerosol, and
monitored over time for their ability to (a) control infection, (b) develop histopathology at sites
of infection, and (c) survive. WT mice acquired the ability to control and to hold infection at a
stationary level from day 20 on. This was associated with the development of a macrophage-
dominated alveolitis at sites of infection, with increased synthesis of IFN-
 
g
 
 and NOS2 mRNA,
and with an median survival time (MST) of 258.5 d. In the absence of 
 
ab
 
 T cells, Mtb grew
progressively and rapidly to induce a necrotic, neutrophil-dominated lung pathology that killed
 
mice with an MST of 48 d. In the absence of CD4-mediated immunity (class II
 
2
 
/
 
2
 
 mice), pro-
gressive bacterial growth continued in the lungs and in other organs beyond day 20, resulting
in an MST of 77 d. By contrast, in the absence of CD8 T cell–mediated immunity, lung infec-
tion was controlled at a 1 log higher stationary level that induced a similar histopathologic re-
sponse to that of WT mice, and resulted in an MST of 232 d.
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Introduction
 
The rational design of an improved antituberculosis vaccine
will be based, among other things, on a knowledge of the
primary immune response that serves to protect most hu-
mans from the disease, and an understanding of why this
immunity is not generated or expressed efficiently in the
small percentage of humans who are susceptible. According
to recent review articles (1–3), antituberculosis immunity is
mediated by antigen-specific CD4 Th1 and CD8 T cells
with apparent help from 
 
gd
 
 T cells. Most of our under-
standing of the T cells involved in protective anti–
 
Mycobac-
terium tuberculosis (
 
Mtb)
 
1
 
 immunity is based on cause and ef-
fect evidence from studies of tuberculosis in mice in which
the expression of immunity can be measured in terms of
the control of
 
 
 
infection in major organs in the absence of
selected T cell subpopulations (4). Our knowledge of the T
cells involved in immunity to human tuberculosis, on the
other hand, is based on correlative evidence that comes
from experiments designed to identify T cells that respond
to appropriately presented Mtb antigens in vitro. Although
there is general agreement that all of the aforementioned T
cells participate in the immune response in both host spe-
cies, disagreement remains about the relative importance of
each in protective immunity. For example, although most
evidence favors a dominant role for CD4 Th1 cell–medi-
ated immunity, it has been argued by some that CD8 T
cells are more important (5) or equally important (6, 7),
whereas still others claim (8) that CD8 T cells play no pro-
tective role at all. Again, in spite of numerous publications
showing that Mtb-specific 
 
gd
 
 T cells are generated in re-
sponse to Mtb infections (9), and one publication showing
that these T cells contribute significantly to protective im-
munity in mice (10), a more recent study suggests (11) that
 
gd
 
 T cells, like B cells (12), contribute little to protective
immunity in mice. Again, although there is evidence (13,
14) that class Ib (CD1)-dependent immunity might be in-
volved in the response to Mtb infection in humans, it has
recently been shown (15) that this component of immunity
plays no obvious role in protective immunity in mice. This
makes it unlikely that NK
 
1
 
CD4
 
2
 
CD8
 
2
 
 
 
ab 
 
T cells are in-
volved in the expression of immunity in this host species.
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Therefore, as far as the mouse model is concerned, it is
mainly the importance of CD8 relative to CD4 T cells that
needs clarification. Confusion that exists about this subject
is partly a consequence of the fact that the role of these T
cell subsets in anti-Mtb immunity in mice has not been in-
vestigated with a standard mouse model of infection. In-
stead, it has been investigated with models that have dif-
fered with regards to the mouse strain employed, the strain
and number of Mtb inoculated, and route of inoculation.
Moreover, in recent key studies of the role of CD8 T cells
in anti-Mtb immunity (7, 15), the contribution of CD4 T
cells was not determined concurrently for comparison.
Given the importance that now seems to be attributed to
CD8 T cells in vaccine development (16–19), there is a
need to determine whether these T cells are as essential to
immunity as appears to be generally believed. This would
require that their contribution be compared with that of
CD4 T cells and other T cells in a single study that uses
mice of a single strain infected via the natural route of in-
fection with a small number of a given strain of virulent
Mtb. This paper shows that when such a study is per-
formed, CD8 T cells, in contrast to CD4 T cells, are seen
not to be essential for the control of infection.
 
Materials and Methods
 
Mice.
 
All mice were of the C57BL/6 strain. Wild-type (WT)
mice and mice with targeted disruption of the gene for IFN-
 
g
 
(IFN-
 
g
 
2
 
/
 
2
 
), inducible nitric oxide synthase (NOS2
 
2
 
/
 
2
 
), 
 
b
 
2-
microglobulin (class I
 
2
 
/
 
2
 
), and H-2A
 
b
 
 chain (class II
 
2
 
/
 
2
 
) were
purchased from the Trudeau Institute Animal Breeding Facility.
Mice deleted of the gene for TCR-
 
a
 
 chain (TCR-
 
a
 
/
 
b
 
2
 
/
 
2
 
) or
the gene for the TCR-
 
d
 
 chain (TCR-
 
gd
 
2
 
/
 
2
 
) were purchased
from The Jackson Laboratory. Mice were used in experiments
when they were between 8 and 10 wk of age.
 
Bacteria and Infection.
 
Mtb, strain H37Rv (Trudeau Mycobac-
terial Culture collection no. 102), originally obtained from the
Trudeau Mycobacterial Culture collection, was grown as a sus-
pension culture in Proskauer and Beck medium containing 0.01%
Tween 80, and harvested while in log-phase growth, as described
previously (20). The culture was subjected to two 5-s bursts of ul-
trasound to break up clumps, and diluted in PBS containing
0.01% Tween 80 for infection via the respiratory route. This was
done in an aerosol infection apparatus (Tri Instruments), and in-
volved exposing mice to an aerosol generated by nebulizing 10
ml of a suspension of 10
 
6
 
 bacilli/ml for 30 min. At the times indi-
cated, mice were killed and their lungs, livers, and spleens were
removed and homogenized on ice with motorized Teflon pestles
in close-fitting glass tubes containing PBS-Tween. The homoge-
nates were subjected to 10-fold serial dilution and the dilutions
plated on enriched Middlebrook 7H11 agar. Colonies were
counted after 2–3 wk incubation at 37
 
8
 
C. Survival studies were
done with 10 mice per group. Significance of differences between
means was determined with Student’s 
 
t
 
 test, and differences be-
tween survival times determined with the Logrank test using
GraphPad Prism v3 for Windows (GraphPad Software).
 
mAb Depletion of T Cells.
 
Mice were thymectomized at 3 wk
of age by making a midline incision along the sternum, opening
the sternum with retractors, removing the exposed thymus by
suction, and closing the incision with surgical clips. The mice
were infused intraperitoneally 4 and 5 wk later with 0.5 mg of
 
monoclonal rat anti–mouse CD4 mAb (clone GK1.5), anti–
mouse CD8 mAb (clone TIB 210), or with both mAbs. They
were infused again with the same mAbs 2 wk later, and used in
experiments after a further 2 d.
 
Ribonuclease Protection Assay.
 
The lungs of noninfected mice
and mice infected by aerosol with 10
 
2
 
 CFU of H37Rv 0, 10, 20,
30, or 50 d earlier were removed and snap frozen in liquid nitro-
gen. The frozen lungs were later homogenized and RNA ex-
tracted with Trizol reagent (Life Technologies). Detection of
mRNA for NOS2, IL-4, IL-10, IL-13, IL-2, IL-2R-
 
a
 
, and IFN-
 
g
 
was performed using the RiboQuant Multiprobe Ribonuclease
Protection Assay System (BD PharMingen) as detailed by the
manufacturer. Radiolabeling of antisense RNA probes was done
using 1,250 Ci/mMol [
 
35
 
S]UTP (ICN Biomedicals) at a concen-
tration of 1.5 
 
3 
 
10
 
6
 
 cpm/
 
m
 
l. For detection of cytokine lung
mRNA, 2 
 
m
 
l of labeled probe solution was added to 20 
 
m
 
g of
RNA in manufacturer’s hybridization buffer, heated to 90
 
8
 
C, and
incubated overnight at 56
 
8
 
C. The hybridized RNA was treated
with RNase for 45 min at 30
 
8
 
C followed by treatment with Pro-
teinase K for 15 min at 37
 
8
 
C. Hybridized RNA was precipitated
with ethanol and electrophoresed in a standard 5% acrylamide/8 M
urea gel.
 
Histology and Immunocytochemistry.
 
Lungs were fixed in 10%
neutral buffered formalin for 18 h, washed in distilled water, de-
hydrated in ethanol, and embedded in wax, according to standard
procedures. Paraffin sections were cut on a rotary microtome,
stained for acid-fast bacteria by a modified basic fuchsin stain (21),
and counter stained with methylene blue or azure A and eosin.
Immunocytochemistry to detect NOS2 in lung sections involved
reacting deparifinized lung sections with 0.1 
 
m
 
g/ml of affinity-
purified monospecific rabbit Ig anti–mouse NOS2 (Transduction
laboratories) as the primary Ab. After washing, the sections were
reacted with biotinylated goat Ig anti–rabbit Ig as the second re-
agent, and after washing they were incubated with avidin-cou-
pled biotinylated horseradish peroxidase with diaminobenzidine
as substrate (Vectastain ABC Kit; Novocastra Laboratories Ltd.)
to produce the reaction product, according to the supplier’s in-
structions. Photomicrographs were taken with a Microphot-Fx
microscope (Nikon).
 
Results
 
Mycobacterial Growth and Host Survival in the Absence of Se-
lected T Cell Subsets.
 
The ability of WT mice and mice
devoid of 
 
ab
 
 or 
 
gd
 
 T cells to control infection initiated
with 
 
z
 
10
 
2
 
 H37Rv given via the respiratory route is shown
in Fig. 1. H37Rv grew in the lungs of WT mice for 
 
z
 
20 d
to reach 
 
z
 
6.5 logs, after which infection was controlled
and caused to become approximately stationary by acquired
immunity. In these mice, infection was not detected in the
livers and spleens until 
 
z
 
day 20, and progressed very little
thereafter, almost certainly because immunity had been ac-
quired systemically. In the absence of 
 
ab
 
 T cells, H37Rv
continued to grow in all three organs beyond day 20 to
reach very large numbers by day 50, at which time most
animals were dead. On the other hand, the absence of 
 
gd
 
 T
cells had no effect on the growth of H37Rv in any organ
during the 150-d period of the experiment.
The relative importance of CD8 versus CD4 
 
ab
 
 T cells
in immunity is shown in Fig. 2, where it can be seen that
mice incapable of generating CD4 T cell–mediated immu- 
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nity (class II
 
2
 
/
 
2
 
 mice) were incapable of controlling bacte-
rial growth in their lungs and other organs after day 20, al-
though the rate of bacterial growth was slower than in the
organs of mice devoid of 
 
ab
 
 T cells. The absence of CD8
T cell–mediated immunity (class I
 
2
 
/
 
2
 
 mice) was of much
less consequence, in that it resulted in Mtb growth con-
tinuing in the lungs beyond day 20 at a slower rate than in
class II
 
2
 
/
 
2
 
 mice. Moreover, the absence of CD8 T cells
caused only a 1 log higher level of stationary lung infection
than in WT mice. This was achieved sometime after day
40. Infection in the livers and spleens of class I mutant mice
also persisted at about a 1 log higher level than in WT
mice, thus indicating that the ability to stabilize infection
was acquired in all organs.
The effect on host survival of the absence of different T
cell subpopulations is shown in Figs. 3 and 4. Fig. 3 also
shows the survival times of mice incapable of generating
IFN-
 
g 
 
or NOS2. These mice were included in the study
because it is known that in order for immunity to be ex-
pressed, NOS2-dependent NO and reactive nitrogen inter-
mediates (RNIs) need to be generated by macrophages (22,
23), and it is believed that this is dependent on IFN-
 
g
 
 se-
creted by Mtb-specific T cells (24, 25). Therefore, the con-
sequence of not being able to synthesize either molecule
should be similar to that of not being able to generate 
 
ab
 
 T
cell–mediated immunity. It can be seen in Figs. 3 and 4
that, whereas WT mice died with a median survival time
(MST) of 258.5 and 313.5 d, respectively, the MSTs of
IFN-
 
g
 
2
 
/
 
2
 
, NOS2
 
2
 
/
 
2
 
,
 
 
 
TCR-
 
a
 
/
 
b
 
2
 
/
 
2
 
, class II
 
2
 
/
 
2
 
, and class
I
 
2
 
/
 
2
 
 mice were 32, 39, 48, 77, and 232.6 d, respectively.
The differences in MST between TCR-
 
a
 
/
 
b
 
2
 
/
 
2
 
 and IFN-
 
g
 
2
 
/
 
2
 
 mice, and between IFN-
 
g
 
2
 
/
 
2
 
 and NOS2 mice, were
statistically significant (
 
P 
 
5
 
 0.0039 and 0.0001, respec-
tively) by Logrank test. Mice devoid of 
 
gd
 
 T cells died
with a MST of 243.5 d, which was not significantly differ-
ent (
 
P
 
 
 
5 
 
0.2) from WT mice.
Figure 1. Growth of H37Rv in
the lungs, livers, and spleens of
WT, TCR-a/b2/2, and TCR-
g/d2/2 mice infected with 102
CFU via the respiratory route.
WT and TCR-g/d2/2 controlled
infection and caused it to become
stationary in all organs after day 20,
whereas TCR-a/b2/2 mice were
unable to control infection in any
organ. This is one of two experi-
ments that gave essentially the
same results. Means of five mice
per time point per group 6 SD.
Figure 2. Growth of H37Rv in
the lungs, livers, and spleens of WT,
class I2/2, and class II2/2 mice in-
fected with 102 H37Rv via the res-
piratory route. Infection in class I2/2
mice was stabilized in the lungs and
other organs at a 1 log higher level
than in WT mice. Class II2/2 mice
were unable to control infection in
any organ. This is one of two exper-
iments that gave essentially the same
results. Means of five mice per time
point per group 6 SD.
Figure 3. Survival times of WT, TCR-a/b2/2, TCR-g/d2/2, IFN-
g2/2, and NOS22/2 mice (10 mice per group) infected with 102 H37Rv
via the respiratory route. IFN-g2/2 mice died earlier (MST 5 32 d) than
NOS22/2 mice (MST 5 39 d), and NOS22/2 mice died earlier than
TCR-a/b2/2 mice (MST 5 48). TCR-g/d2/2 mice died with an MST
of 243.5 d, which was not significantly different from the 258.5-d MST
of WT mice.
Figure 4. Survival times of WT (MST 5 313.5 d), class I2/2 (MST 5
232 d), and class II2/2 (MST 5 77 d) mice (10 per group) infected with
102 H37Rv via the respiratory route.274 T Cell Subsets in Antituberculosis Immunity
To determine whether the susceptibility of mice without
ab T cell subsets as shown above was due entirely to the
absence of CD4 and CD8 T cells, mice depleted of either,
or both, subsets of T cells by treatment with mAbs were in-
fected with 102 CFU of Mtb by aerosol, and their survival
monitored. The results in Fig. 5 show that, whereas un-
treated mice died with an MST of 289.5 d, mice depleted
of CD4 T cells or CD8 T cells died with an MST of 82 or
256 d, respectively. Mice depleted of both T cell subsets
died with an MST of 50 d. Therefore, the results with T
cell–depleted mice were essentially the same as those ob-
tained with MHC mutant mice.
IFN-g and NOS2 mRNA Synthesis in Response to Infec-
tion. According to the foregoing results, growth of Mtb
in the lungs was maintained at a stationary level from day
20 on. It could be argued, therefore, that immunity would
need to be continuously mediated and expressed in the
lungs from day 20 on, as would be evidenced by the con-
tinuous synthesis of mRNA for IFN-g and NOS2. This
was investigated in WT and targeted mutant mice by mul-
tiprobe ribonuclease protection assay (RPA) analysis of
RNA from lungs harvested at progressive stages of infec-
tion (Figs. 6 and 7). The results in Fig. 6 show that in the
case of WT mice, NOS2 mRNA was constitutively syn-
thesized in the lungs at low levels before infection was ini-
tiated, and that its synthesis was substantially upregulated
from day 20 of infection on. IFN-g mRNA was also syn-
thesized in larger quantity in the lungs of WT mice from
day 20 on, as was IL-4 mRNA, although in quantities too
small to be visible in the figure. The presence of IL-4
mRNA was clearly visible in the original radioautograph.
IL-10, IL-13, and IL-2 mRNAs were not detected in mea-
surable quantities under the conditions of the assay. It will
be noted (Figs. 6 and 7) that IL-15 mRNA was constitu-
tively present in the lungs, and that its synthesis appeared
not to be substantially altered in response to infection.
In TCR-a/b2/2 mice (Fig. 6), lung IFN-g synthesis
was not detected until day 30 and remained at a lower level
than in WT mice through day 50. The synthesis of NOS2
mRNA was upregulated from day 20 through day 50 in
the lungs of these mice, although apparently at a lower
level than in WT mice. In the lungs of class I2/2 mice (Fig.
7), increased synthesis of IFN-g and NOS2 mRNA was
upregulated from day 20 of infection to levels similar to
those reached in WT mice. In class II2/2 mice, in contrast,
the level of IFN-g mRNA synthesis in the lungs was al-
most undetectable at day 20, but increased to relatively low
levels on days 30 and 50. Likewise, NOS2 mRNA in class
II2/2 mice was not synthesized in lungs of these mice in
appreciable amounts before day 30.
It was considered improper to attempt to quantify rela-
tive changes in the levels of IFN-g and NOS2 mRNA
Figure 5. The survival times of mice depleted of CD4, CD8, or both
T cell subsets by treatment with mAbs were similar to survival times of
class II2/2, class I2/2, and TCR-a/b2/2 mice, respectively, as shown in
Fig. 4. All mice (10 per group) were infected by aerosol with 102 H37Rv.
Figure 6. Radioautograph of
multiprobe RPA run using 35S-
labeled probes to detect mRNA
for IFN-g, NOS2, IL-4, IL-13,
IL-15, and IL-2Ra in the lungs
of WT and TCR-a/b2/2 mice
on days 0, 10, 20, 30, and 50 of
infection. The results clearly
show upregulation of mRNA for
NOS2 and IFN-g from day 20
of infection in WT mice. Much
less IFN-g mRNA was present
in the lungs of TCR-a/b2/2
mice from day 30 on, and the
production of NOS2 mRNA
was delayed. IL-15 mRNA was
constitutively produced in the
lungs of both groups of mice,
and its synthesis appeared to
be little altered by infection.
GAPDH, glyceraldehyde 3-phos-
phate dehydrogenase.
Figure 7. Changes in the quantity of mRNA for IFN-g and NOS2
against time of infection in the lungs of WT, class I2/2, and class II2/2
mice as determined by RPA. IFN-g and NOS2 mRNA was upregulated
from day 20 of infection on in WT mice. Likewise, IFN-g and NOS2
mRNA was present in the lungs of class I2/2 mice from days 20 on. In
the lungs of class II2/2 mice, in contrast, upregulation of IFN-g mRNA
was not evident until day 30, and relatively low levels were produced
thereafter. Appreciable amounts of NOS2 mRNA were made in the
lungs of these mice, but not until after day 30. GAPDH, glyceraldehyde
3-phosphate dehydrogenase.275 Mogues et al.
against time of infection by normalizing the density of their
autoradiographic bands to those of the two housekeeping
genes used in the assay. This was because it was obvious
from the RPA results that synthesis of mRNAs for the
housekeeping genes changed appreciably in response to in-
fection. Problems associated with the use of housekeeping
gene mRNAs as internal standards for determining changes
in the quantities of other mRNA species in tissues under
different experimental conditions has been discussed by
others (26, 27). Real-time PCR is currently being used in
this laboratory to quantify changes in IFN-g and NOS2
mRNA on the basis of whole lung mRNA, according to
published methodology (28).
Lung Histopathology and Immunocytochemical Localization of
NOS2. Histology was performed on lungs harvested on
day 50 and day 80 of infection when infection in WT mice
was being held in stationary phase by acquired immunity.
However, only day 50 histology is shown, because certain
mutant mice were dead by day 80. In mice that survived,
day 80 histology was essentially the same as that seen at day
50, except that the lesions were somewhat larger. Low
power microscopy of day 50 lung sections (Fig. 8) serve to
show the size of individual lesions and the extent to which
infection-induced pathology occupied the lungs. For ex-
ample, it can be seen in Fig. 8 that infection-induced pa-
thology was confined to discrete sites that were similar in
appearance, number, and size in the lungs of WT and class
I2/2 mice. In both types of mice, each lesion was com-
posed of lightly stained and heavily stained areas known
from previous studies (20) to represent collections of mac-
rophages and lymphocytes, respectively. The lightly and
densely stained areas are also evident from low power mi-
crographs of sections stained for NOS2 by immunocy-
tochemistry. This is shown in Fig. 9, where it can be seen
that cells that stained positively for NOS2 in the lung le-
sions of WT and class I2/2 mice were confined to the
lightly stained macrophage areas of lesions. At higher
power (Fig. 9), these cells were seen to be epithelioid mac-
rophages with a foamy cytoplasm. Acid-fast staining
showed that NOS2-positive macrophages contained Mtb
bacilli, and that more bacilli were present in macrophages
of class I2/2 mice than in macrophages of WT mice. This is
in keeping with higher level of lung infection in the former
mice, in agreement with growth curves shown in a preced-
ing section. Thus, in the lungs both of WT and class I2/2
mice the histological response at each site of infection con-
sisted of a localized alveolitis dominated by NOS2-positive
macrophages and by lymphocytes. Examination of numer-
ous sections indicated that at day 80 of infection, the lung
lesions in class I2/2 mice were somewhat larger than in
WT mice. This was also evident from macroscopic exami-
nation of whole lungs at the time of sacrifice.
The lung lesions of class II2/2 mice on day 50 (Fig. 8)
were smaller, more numerous, less well organized, and oc-
cupied a smaller proportion of the lung volume than in the
case of WT and class I2/2 mice. The lesions were almost
completely made up of lightly stained cells that at higher
power (Fig. 9) were seen to be macrophages, many of
which stained positively for NOS2. It is also evident that
macrophages that were positive for the enzyme were
heavily infected with acid-fast bacilli. However, some in-
fected macrophages contained little or no NOS2 reaction
product (not shown). Moreover, many of the infected
macrophages did not display a foamy cytoplasm typical of
that of epithelioid macrophages seen in the lungs of WT
and class I2/2 mice. Overall, the smaller number of cells
Figure 8. Low power (36.5)
of 15-mm thick sections of the
left lobe of lungs of a WT (a)
class I2/2 (b), class II2/2 (c), and
TCR-a/b2/2 (d) mouse on day
50 of infection initiated with 102
H37Rv by aerosol. The individ-
ual lesions in WT and class I2/2
mice are very similar in size and
appearance, being made up of
darkly stained (lymphoid) and
lightly stained (macrophage) ar-
eas. The lung lesions in class
II2/2 mice are smaller and less
well defined, whereas the lung
lesions in TCR-a/b2/2 mice are
large, darkly stained, and granu-
lar in appearance.276 T Cell Subsets in Antituberculosis Immunity
showing NOS2 reaction product in class II2/2 mice is in
keeping with the low levels of lung NOS2 mRNA dem-
onstrated by RPA.
The lung lesions of TCR-a/b2/2 mice at low power
(Fig. 8) were distinctly different in appearance from those
in other types of mice. At day 50 they were larger and
more numerous and collectively appeared to occupy a sub-
stantial proportion (z50%) of the lung volume. Their his-
tology showed no resemblance to that of lesions in WT,
class I, or class II mutant mice. It was made up (Fig. 9) of
an exudative, necrotic pneumonitis dominated by neutro-
phils. Moreover, the lungs as a whole were obviously
edematous and individual air sacs were swollen to the ex-
tent that their outpocketings (alveoli) were abolished. The
cells within these air sacs were heavily infected with acid-
fast bacteria, in keeping with the very large numbers of
Figure 9. Low power (325)
and high power (3550) micro-
graphs of lung sections of a WT
(a and b), class I2/2 (c and d),
class II2/2 (e and f), and TCR-
a/b2/2 mouse (g and h) stained
for NOS2 by immunocyto-
chemistry. At low power, the
immunocytochemical reaction
product is seen to be located in
cells in the lightly stained mac-
rophage areas of the lesions of
WT and class I2/2 mice. In class
II2/2  and TCR-a/b2/2  mice,
the reaction product is scattered
in smaller quantity in cells
throughout the lesions. At high
power, the reaction product is
seen confined to macrophages in
lesions of WT and class I2/2
mice, with some of the mac-
rophages containing acid-fast ba-
cilli. The NOS2-positive mac-
rophages of the class I2/2 mouse
contain more acid-fast bacilli
than NOS2-positive macrophages
in WT lesion. In the lesion of
the class II2/2 mouse, NOS2-
positive macrophages are heavily
infected with Mtb, although
some heavily infected macro-
phages have little or no reaction
product. In the lesion of the
TCR-a/b2/2  mouse, most of
the NOS2 reaction product ap-
pears to be concentrated in scat-
tered mononuclear cells.277 Mogues et al.
Mtb CFUs in the lungs, as shown in a preceding section.
Immunocytochemistry showed (Fig. 9) that NOS2 staining
was concentrated in mononuclear cells scattered through-
out the lesions. However, the majority of cells in lesions,
including those that were infected, did not stain for NOS2.
Discussion
It is known that tuberculosis in mice (20, 29), like tuber-
culosis in .85% of immunocompetent humans (30), is a
progressive chronic disease confined to the lungs. It is only
in this organ that infection-induced pathology is progres-
sive and extensive enough to compromise organ function
and cause death. However, in order for the disease in mice
to resemble that in humans, it is necessary to infect mice
with a small enough number of bacilli to ensure long-term
survival, otherwise chronic lung pathology does not have
time to develop. This was the rationale for infecting mice
with 1–2 3 102 CFU of H37Rv via the respiratory route
in the study reported here. It is shown that implantation of
this number of Mtb in the lungs of WT mice resulted in
progressive bacterial multiplication for z20 d, after which
multiplication was controlled and infection caused to be-
come approximately stationary under the influence of ac-
quired immunity. That lung infection with Mtb in mice
enters a stationary phase under the influence of host immu-
nity was convincingly demonstrated many years ago by
McCune and Tompsett (31), and more recently by Schell
et al. (32). The same has been shown to be true for Mtb in-
fection in guinea pigs (33) and rabbits (34). However, be-
cause progressive lung disease (pathology) develops in all
three-host species, stationary infection does not represent a
state of tuberculosis latency. It needs to be mentioned,
moreover, that conversion of lung infection from progres-
sive to stationary phase is not achieved by mice belonging
to strains that are genetically more susceptible than the
C57BL/6 strain (35).
In keeping with previous studies (20, 35), each lung le-
sion in WT mice at day 50 of infection is shown here to
consist of a discrete area of alveolitis dominated by epithe-
lioid macrophages, some of which contain Mtb bacilli.
Large accumulations of lymphoid cells at the periphery and
within the lesions obviously represented a major cellular
component of the response, although it is not known
whether all of the lymphocytes contributed to protective
immunity. According to previous studies (20, 36), station-
ary infection in the lungs of WT mice causes lesions to in-
crease progressively in size and the interstitium within le-
sions to expand and become fibrotic. Eventually, lesions
coalesce and lung consolidation becomes extensive enough
to kill mice with a MST of .250 d. Therefore, these re-
sults, like those published previously (20), show that im-
munity to primary infection neither causes infection to re-
solve nor prevents disease from developing.
It was expected, as shown here, that the onset of control
of Mtb growth at infectious foci in the lungs of WT mice
from day 20 of infection on would be temporally associated
with increased synthesis of mRNA for IFN-g and for
NOS2. It was also expected that stationary infection would
be associated with the synthesis of NOS2 in macrophages
at infectious foci, as revealed by immunohistochemistry.
Thus, stationary lung infection is shown here to be associ-
ated with the continuous synthesis of mRNA for a key
Th1 cytokine involved in mediation of immunity (34, 25)
and with the synthesis by macrophages of an inducible en-
zyme necessary for the rapid production of NO and reac-
tive nitrogen intermediates essential for the expression of
immunity (22). We have also shown (to be published) that
NOS2 and IFN-g mRNA are continuously synthesized in
the lungs for at least 150 d of infection. Relevant to these
findings is a published finding (22) showing that inhibition
of NOS2-dependent NO production in mice with station-
ary infection by treatment with N6-(iminoethyl) lysine re-
sulted in resumption of Mtb growth. A similar resumption
of Mtb growth was shown to occur in mice treated with
the less specific inhibitor of NOS2-dependent NO produc-
tion, aminoguanidine (37), and in mice selectively depleted
of CD4 T cells (38).
As for the response to Mtb infection in class I2/2 mice,
there is no doubt from this study that the pathology seen in
the lungs of these mice was qualitatively similar to that seen
in WT mice. This was to be expected, given that class I2/2
mice, like WT mice, were able to eventually stabilize in-
fection and cause it to become approximately stationary, al-
beit at a 1 log higher level. As this higher level of infection
was caused by about a 30-d delay before infection became
stationary, it follows that CD8 T cells, in addition to CD4
T cells, contributed significantly to the control bacterial
growth during this period. Whether CD8 cells help to
maintain infection at a stationary level at later times of in-
fection is not known. However, the fact that stabilization
of infection is achieved by class I2/2 mice means that CD8
T cells are not needed to eventually stop infection from
progressing, even after it reaches a 1 log higher level. A re-
cently published study of mice infected with much higher
numbers of Mtb via the intravenous route (39) also shows
that lung infection is controlled and becomes stationary in
the absence of CD8 T cell–mediated immunity. The pres-
ence of a higher level of stationary infection in class I2/2
mice undoubtedly was the reason why lung lesions in these
mice eventually increase in size at a faster rate than those in
WT mice. This is not surprising, given that a 1 log higher
level of stationary infection represents 10 times more bacilli
per lesion and a larger bacterial load per macrophage. This
presumably would represent a larger antigen load per mac-
rophage and a larger intracellular stimulus for the produc-
tion of chemokines and proinflammatory cytokines by
macrophages. It is not surprising, therefore, that the sur-
vival time of class I2/2 mice was shorter, although not
much shorter (25%) than that of WT mice. Presumably,
both types of mice died of Th1-mediated chronic lung dis-
ease.
The survival time of class II2/2 mice, in contrast, was
substantially shorter (86%) than that of WT mice. More-
over, because infection was progressive in all organs in class
II2/2 mice, it seems likely that death was caused by pathol-278 T Cell Subsets in Antituberculosis Immunity
ogy in multiple organs induced by overwhelming systemic
infection. According to the histology of the lungs of class
II2/2 mice, there was not enough disease in these organs
between days 50 and 80 to cause death. On the other hand,
there was extensive pathology in the liver and spleen (un-
published results). Regardless, there can be little doubt
from this study that class II2/2 mice were greatly more sus-
ceptible to Mtb infection than class I2/2. Indeed, if success-
ful immunity in the mouse model of tuberculosis is defined
as the ability to cause infection to become stationary rather
than to resolve, then class I2/2 mice, but not class II2/2
mice, were capable of expressing successful immunity. The
delayed synthesis of lower levels of IFN-g mRNA in the
lungs of class II2/2 mice is in keeping with their failure to
mediate protective immunity. The inability of these mice
to stabilize lung infection when detectable amounts of
IFN-g and NOS2 mRNA were eventually synthesized
might indicate that activated macrophages are capable of
exerting only a limited inhibitory effect on intracellular
Mtb growth after the load of Mtb per macrophage in-
creases above a certain threshold. Threshold numbers were
reached because of the delay in the expression of immu-
nity, as evidenced by the delay in synthesis of IFN-g and
NOS2.
It seems likely that most of the IFN-g mRNA that was
present in the lungs of class II2/2 mice was synthesized by
CD8 T cells and possibly NK cells. Even so, the exact way
that CD8 T cells mediate immunity in WT and class II2/2
mice is not known. According to one study (40), the ability
of these cells to synthesize IFN-g is essential for their abil-
ity to express immunity. Whether they also function to lyse
infected host cells in vivo remains to be shown, although
evidence obtained with gene knockout mice indicates that
neither perforin-dependent nor Fas-dependent lysis is
likely to be involved (41, 42). It is possible, on the other
hand, that CD8 T cells are protective by virtue of their
ability to make granulysin, a molecule known to be directly
toxic for Mtb in vitro according to studies with human
CD8 T cells (43). However, according to the study pre-
sented here none of these functions of CD8 T cells is essen-
tial for stabilization of Mtb infection in mice. Presumably,
the absence of CD8 T cells is compensated for by an ex-
pansion in the number of CD4 T cells in lesions, or by up-
regulation of cytokine and chemokine production by indi-
vidual CD4 T cells in response to a higher level of
stationary infection at infectious foci.
Perhaps the most compelling evidence presented here
that CD8 T cells contribute to immunity is the demonstra-
tion that their presence in class II2/2 mice prevented the
massive exudative, inflammatory response seen in the lungs
of mice devoid of both subsets of ab T cells. The strikingly
greater resistance of class II2/2 mice compared with ab T
cell2/2 mice presumably was due to the ability of CD8 T
cells to create conditions that favor the extravasation and
accumulation of macrophages, rather than neutrophils, at
sites of Mtb growth. Indeed, the results show that lung le-
sions in class II2/2 mice, although small and disorganized,
were dominated by macrophages, at least up to day 80 of
infection. However, unlike macrophages in lesions of WT
and class I2/2 mice, many infected macrophages in lesions
of class II2/2 mice appeared morphologically less mature
and contained much larger numbers of acid-fast bacilli.
Moreover, although many of these heavily infected mac-
rophages stained for NOS2, many did not. It was also ap-
parent that Mtb had multiplied just as much in NOS2-
positive as in NOS2-negative macrophages, presumably
because Mtb numbers had become too high for macro-
phages to control by the time NOS2 synthesis was upregu-
lated.
Because survival results obtained with class II2/2 and
class I2/2 mice were reproduced with mice depleted of
CD4 and CD8 T cells by mAb treatment, it is unlikely that
cells in addition to CD8 T cells contribute significantly to
resistance in class II2/2 mice. It was also found as part of
this study (results not presented) that CD8 and CD4 gene–
deleted mice were somewhat less susceptible to tuberculosis
than class I2/2 and class II2/2 mice respectively. This pre-
sumably was because of the ability of T cells to respond to a
limited extent to Ags in the absence CD4- and CD8-medi-
ated costimulation. Taken as a whole, the results presented
show that the absence of CD8 T cells in mice infected with
a small number of Mtb via the respiratory route was of
much less consequence to survival than was shown by oth-
ers (7, 15, 39) for mice infected with a larger number via
the intravenous route. A possible explanation for this dis-
agreement is that inoculation of 105 or 106 CFU of Mtb via
the intravenous route results in a much larger total bacterial
burden with which CD4 T cells need to deal. According to
the bacterial growth curves in the publications cited, giving
over 105 Mtb via the intravenous route resulted in over 3
logs of bacteria implanting in the lungs at the start of infec-
tion. Assuming that each CFU that implants gives rise to a
separate site of infection at which pathology can develop, it
is not surprising that mice so infected died much earlier
than mice with 10-fold fewer lung lesions, as shown in the
study reported here. Unfortunately, it is not known
whether mice devoid of CD4 T cell–mediated immunity
would have died earlier or later from a 105 or 106 intrave-
nous inoculum than mice devoid of CD8 T cell–mediated
immunity, as class II2/2 mice were not included in the
studies for comparison. Regardless, even in the case of large
intravenous inocula, the absence of CD8 T cell–mediated
immunity did not prevent mice from stabilizing infection at
a higher level and causing it to become stationary (39).
Lastly, the finding that mice devoid of gd T cells were
not deficient in an ability to stabilize infection is in keeping
with results published by others (11). The additional find-
ing that these mice had the same survival time as WT mice
suggests that if gd T cells function to regulate infection-
induced inflammation in the lung, as has been proposed
(11), it is unlikely that this regulatory function is relevant to
either the expression of protective immunity or to infec-
tion-induced pathology that eventually causes death.
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